Dr. Ruanne Barnabas of the University of Washington School of Public Health has received a more than $100,000 award from the World Health Organization (WHO) to lead research that aims to shed light on effective strategies for cervical cancer elimination. The study will increase understanding of how a combination of screening and vaccination strategies can be used more effectively to eliminate cervical cancer in low- and middle-income countries.
Dr. Barnabas is associate professor in the UW’s Department of Global Health. The research team will use mathematical models to evaluate the impact of vaccination and screening in South Africa and Kenya, while accounting for human papillomavirus-human immunodeficiency virus (HPV-HIV) interactions. The project is part of WHO’s 2019 Global Strategy towards the Elimination of Cervical Cancer.
“Given that women living with HIV have two to five times higher risk for cervical cancer, it is critical to understand the impact of current strategies for cervical cancer elimination among this population,” Dr. Barnabas said. “There are many promising interventions, but what combination of strategies are needed to effectively and efficiently eliminate cervical cancer in low and middle income countries (LMICs)? This study will help reveal what else is needed – who needs to be screened, when they need to be screened, and more.”Friday Letter Submission, Publish on December 13